{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:06:54Z","timestamp":1778972814069,"version":"3.51.4"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,16]]},"DOI":"10.7759\/cureus.108986","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:18:22Z","timestamp":1778969902000},"source":"Crossref","is-referenced-by-count":0,"title":["Sustained Hematological Stability During Clozapine Rechallenge With Adjunctive Lithium: A Case Report of 15-Month Follow-Up"],"prefix":"10.7759","author":[{"given":"Karim","family":"Hamda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azeddine","family":"Barkiat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siham","family":"Belbachir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abderrazzak","family":"Ouanass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis","volume":"209","author":"Siskind D","year":"2016","unstructured":"Siskind D, McCartney L, Goldschlager R, Kisely S. Clozapine v. first- and second-generation antipsychotics in treatment-refractory schizophrenia: systematic review and meta-analysis. Br J Psychiatry. 2016, 209:385-92. 10.1192\/bjp.bp.115.177261","journal-title":"Br J Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.schres.2023.03.032","article-title":"Risks and benefits of clozapine and lithium co-prescribing: a systematic review and expert recommendations","volume":"268","author":"Verdoux H","year":"2024","unstructured":"Verdoux H, Quiles C, de Leon J. Risks and benefits of clozapine and lithium co-prescribing: a systematic review and expert recommendations. Schizophr Res. 2024, 268:233-42. 10.1016\/j.schres.2023.03.032","journal-title":"Schizophr Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MJT.0000000000000715","article-title":"Clozapine rechallenge after major adverse effects: clinical guidelines based on 259 cases","volume":"25","author":"Manu P","year":"2018","unstructured":"Manu P, Lapitskaya Y, Shaikh A, Nielsen J. Clozapine rechallenge after major adverse effects: clinical guidelines based on 259 cases. Am J Ther. 2018, 25:e218-23. 10.1097\/MJT.0000000000000715","journal-title":"Am J Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.6.576","article-title":"Active monitoring of 12760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance","volume":"175","author":"Munro J","year":"1999","unstructured":"Munro J, O'Sullivan D, Andrews C, Arana A, Mortimer A, Kerwin R. Active monitoring of 12760 clozapine recipients in the UK and Ireland: beyond pharmacovigilance. Br J Psychiatry. 1999, 175:576-80. 10.1192\/bjp.175.6.576","journal-title":"Br J Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-815510","article-title":"Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics","volume":"37","author":"Bender S","year":"2004","unstructured":"Bender S, Grohmann R, Engel RR, Degner D, Dittmann-Balcar A, R\u00fcther E. Severe adverse drug reactions in psychiatric inpatients treated with neuroleptics. Pharmacopsychiatry. 2004, 37:S46-53. 10.1055\/s-2004-815510","journal-title":"Pharmacopsychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0311-1","article-title":"Worldwide differences in regulations of clozapine use","volume":"30","author":"Nielsen J","year":"2016","unstructured":"Nielsen J, Young C, Ifteni P, et al.. Worldwide differences in regulations of clozapine use. CNS Drugs. 2016, 30:149-61. 10.1007\/s40263-016-0311-1","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S83989","article-title":"Rare and very rare adverse effects of clozapine","volume":"11","author":"De Fazio P","year":"2015","unstructured":"De Fazio P, Gaetano R, Caroleo M, et al.. Rare and very rare adverse effects of clozapine. Neuropsychiatr Dis Treat. 2015, 11:1995-2003. 10.2147\/NDT.S83989","journal-title":"Neuropsychiatr Dis Treat"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/479386-sustained-hematological-stability-during-clozapine-rechallenge-with-adjunctive-lithium-a-case-report-of-15-month-follow-up","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:18:23Z","timestamp":1778969903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/479386-sustained-hematological-stability-during-clozapine-rechallenge-with-adjunctive-lithium-a-case-report-of-15-month-follow-up"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,16]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.108986","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,16]]}}}